These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update. Dispenzieri A; Coelho T; Conceição I; Waddington-Cruz M; Wixner J; Kristen AV; Rapezzi C; Planté-Bordeneuve V; Gonzalez-Moreno J; Maurer MS; Grogan M; Chapman D; Amass L; Orphanet J Rare Dis; 2022 Jun; 17(1):236. PubMed ID: 35717381 [TBL] [Abstract][Full Text] [Related]
9. A natural history analysis of asymptomatic Coelho T; Conceição I; Waddington-Cruz M; Keohane D; Sultan MB; Chapman D; Amass L; Amyloid; 2022 Dec; 29(4):228-236. PubMed ID: 35730447 [TBL] [Abstract][Full Text] [Related]
10. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years. Wixner J; Suhr OB; Anan I Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):73-81. PubMed ID: 29073801 [TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study. Inês M; Coelho T; Conceição I; Ferreira L; de Carvalho M; Costa J Orphanet J Rare Dis; 2020 Mar; 15(1):67. PubMed ID: 32143656 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Gentile L; Diemberger I; Plante-Bordeneuve V; Mazzeo A; Dori A; Luigetti M; Di Paolantonio A; Dispenzieri A; Grogan M; Waddington Cruz M; Adams D; Inamo J; Kristen AV; Lino Cirami C; Chapman D; Gupta P; Glass O; Amass L PLoS One; 2024; 19(1):e0292435. PubMed ID: 38241252 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience. Luigetti M; Tortora A; Romano A; Di Paolantonio A; Guglielmino V; Bisogni G; Gasbarrini A; Calabresi P; Sabatelli M J Gastrointestin Liver Dis; 2020 Sep; 29(3):339-343. PubMed ID: 32919418 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. Obici L; Suhr OB Clin Auton Res; 2019 Sep; 29(Suppl 1):55-63. PubMed ID: 31452022 [TBL] [Abstract][Full Text] [Related]
15. Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report. Nakov R; Sarafov S; Nakov V; Gospodinova M; Todorov T; Kirov A; Todorova A; Tournev I J Gastrointestin Liver Dis; 2019 Sep; 28(3):359-361. PubMed ID: 31517333 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Waddington-Cruz M; Wixner J; Amass L; Kiszko J; Chapman D; Ando Y; Neurol Ther; 2021 Dec; 10(2):753-766. PubMed ID: 34024024 [TBL] [Abstract][Full Text] [Related]
17. Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS). Cruz MW; Pinto MV; Pinto LF; Gervais R; Dias M; Perez C; Mundayat R; Ong ML; Pedrosa RC; Foguel D Arq Neuropsiquiatr; 2019 Feb; 77(2):96-100. PubMed ID: 30810593 [TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547 [TBL] [Abstract][Full Text] [Related]
19. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS). Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T; PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285 [TBL] [Abstract][Full Text] [Related]
20. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOS. Mora-Ayestaran N; Dispenzieri A; Kristen AV; Maurer MS; Diemberger I; Drachman BM; Grogan M; Gupta P; Glass O; Amass L; Garcia-Pavia P; JACC Adv; 2024 Aug; 3(8):101086. PubMed ID: 39105117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]